Brief: Egetis Therapeutics January March Quarterly Loss Narrows To SEK 19.3 Mln
April 22 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* QUARTERLY NET SALES MSEK 3.8 (11.7)
* JANUARY MARCH QUARTERLY RESULT MSEK -19.3 (-42.8)
Source text for Eikon: ID:nMFN1nXmYL
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1